Case Report: Persistent severe thrombocytopenia after adjuvant ado-trastuzumab emtansine with sequential bone marrow findings and romiplostim support
Dan Qiao, Lei Nie, Shuang Liu, Hai-bin Ding · 2026
Read Case Report: Persistent severe thrombocytopenia after adjuvant ado-trastuzumab emtansine with sequential bone marrow findings and romiplostim support by Dan Qiao, Lei Nie, Shuang Liu, Hai-bin Ding (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13318799.txt.
Description
Dan Qiao and co-authors give a 2026 case report of lasting severe low platelets during breast cancer treatment. A 50-year-old woman received the antibody-drug conjugate T-DM1 after earlier chemotherapy. After three cycles, her platelet count fell to grade 4 severity and stayed low. That pattern breaks the usual cycle of dip and recovery.
Standard platelet-boosting drugs failed to hold her counts. Checks ruled out spleen problems, platelet destruction, and clonal blood disease. Repeated marrow samples showed faulty platelet-producing cell maturation. Counts fell whenever romiplostim stopped and recovered when it restarted. A threshold-based, on-and-off schedule stabilised her levels long term. Further anti-HER2 therapy was withheld to protect her fragile platelet reserve.
Catalog record
| CREATOR | Dan Qiao, Lei Nie, Shuang Liu, Hai-bin Ding |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 23209 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |